Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04058444
Other study ID # 0712960805046
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 19, 2019
Est. completion date June 2020

Study information

Verified date September 2019
Source University of Novi Sad
Contact Borislava Pujic, PhD
Phone +381641503577
Email borislava60@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is designed to help us with ERAS (Enhanced Recovery After Surgery) Protocol for Cesarean Delivery implementation with goal to improve patient satisfaction and decrease length of stay at hospital. This will improve patient treatment and decrease total hospital costs.


Description:

ERAS assumes cooperation between obstetricians, anesthesiologists and parturient. This is the new concept because patient have an active role in the whole process. Pregnant patient receives the first information about ERAS from obstetrician and anesthesiologist before the scheduled cesarean delivery. Patient condition optimization is necessary. Antibiotic prophylaxis, no bowel preparation and arriving to the hospital on the day of surgery are basic principles. All patients are done under spinal anesthesia. DVT (Deep Venous Thrombosis) prophylaxis starts postoperatively. Early mobilization, early oral intake and urinary catheter removal on the day of surgery with multimodal analgesia is mandatory.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date June 2020
Est. primary completion date March 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- All healthy patients from 18-45 years for scheduled Cesarean Delivery

Exclusion Criteria:

- Age younger then 18 years old and older then 45 years

- Urgent and emergent Cesarean Delivery

- Preeclampsia

- Contraindications for spinal anesthesia

- Abnormal placentation

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
ERAS protocol
No routine bowel preparation Antibiotics prophylaxis PONV (Postoperative Nausea and Vomiting) prophylaxis Spinal anesthesia Post- Cesarean analgesia (Acetaminophen 1g IV q6h, Tramadol 50mg IV q6h, Quadratus lumborum Block Oral pain relief medication Pain scores every day (VAS) Hospital length of stay Patient satisfaction

Locations

Country Name City State
Serbia Obstetric and Gynecology Hospital Novi Sad Vojvodina

Sponsors (1)

Lead Sponsor Collaborator
Pujic Borislava

Country where clinical trial is conducted

Serbia, 

References & Publications (3)

Gamez BH, Habib AS. Predicting Severity of Acute Pain After Cesarean Delivery: A Narrative Review. Anesth Analg. 2018 May;126(5):1606-1614. doi: 10.1213/ANE.0000000000002658. Review. — View Citation

Krohg A, Ullensvang K, Rosseland LA, Langesæter E, Sauter AR. The Analgesic Effect of Ultrasound-Guided Quadratus Lumborum Block After Cesarean Delivery: A Randomized Clinical Trial. Anesth Analg. 2018 Feb;126(2):559-565. doi: 10.1213/ANE.0000000000002648 — View Citation

Valentine AR, Carvalho B, Lazo TA, Riley ET. Scheduled acetaminophen with as-needed opioids compared to as-needed acetaminophen plus opioids for post-cesarean pain management. Int J Obstet Anesth. 2015 Aug;24(3):210-6. doi: 10.1016/j.ijoa.2015.03.006. Epu — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Post-Cesarean pain scoring Visual Analog Scale (VAS) for pain assessment (scale from 0-10). Score 0 to 5 is satisfactory pain control. Score 6 to 10 is not a good pain control and is necessary to add medication. Measured from postoperative day (PO) Day 0 to PO day 3 (72 hours)
Secondary Hospital length of stay Length of stay might influence on cost savings. Investigator expects discharge hospital will be on the PO day 3. PO Day 0 until time of discharge PO Day 3-4 (72-96 hours)
Secondary Post-partal depression development Inadequate postoperative treatment could cause chronic pain which could be the reason for post- partal depression development. Six weeks after delivery investigator will call mothers for interview and fill the Edinburgh Postnatal Depression Scale. Score 10 and more is suspect for depression risk. Measured from the Cesarean Delivery to 6 weeks postoperatively
See also
  Status Clinical Trial Phase
Completed NCT03236324 - Transversalis Fascia Plane Blocks for Analgesia Post-cesarean Delivery Phase 2
Completed NCT03150641 - Delayed Cord Clamping at Term Cesarean N/A
Recruiting NCT06247852 - Persistent Pain After Cesarean Delivery - A Danish Multicenter Cohort Study
Completed NCT02846129 - Incidence of Complications Associated With Anesthesia in Multiple Gestation Undergoing Cesarean Delivery N/A
Completed NCT00799955 - Comparing 2 Types of Pain Relief After Cesarean Delivery: Spinal Morphine and TAP Block N/A
Completed NCT03336541 - Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression Phase 4
Completed NCT04358757 - Immune and Physical Recovery Following Cesarean Delivery
Completed NCT01755026 - Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery Phase 4
Recruiting NCT03746678 - Patient-Centred Perioperative Mobile Application
Completed NCT03349151 - Postoperative Results of Early Versus On-demand Maternal Feeding After Cesarean Delivery N/A
Completed NCT03729076 - Crystalloid Versus Colloid Rapid Co-load for Cesarean Delivery Under Spinal Anesthesia N/A
Completed NCT04799587 - Accupressure of P6 to Reduce Nausea During Cesarean Section N/A
Not yet recruiting NCT05758012 - Carbetocin Compared To Oxytocin During Cesarean Delivery
Completed NCT03781388 - ED90 for Hyperbaric Bupivacaine in Super Obese Parturients Phase 4
Completed NCT04349215 - Validation of the Chinese ObsQoR-11
Completed NCT04812223 - Timing of Umbilical Cord Clamping in Term Cesarean Deliveries N/A
Recruiting NCT05279703 - Epinephrine Infusion for Prophylaxis Against Maternal Hypotension During Cesarean Delivery Phase 4
Completed NCT01550640 - Pharmacogenetics of Remifentanil in Patients With Hypertension Undergoing Cesarean Delivery Under General Anesthesia N/A
Completed NCT00884026 - Can Augmentation Index (AIx) be Used to Predict Hypotension After Spinal Anesthesia? N/A
Completed NCT03830307 - NSS-Bridge Device for Post-Cesarean Delivery Pain N/A